|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | (2006.01) |
| A61K 9/1611 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 9/1676 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61K 38/10 | (2013.01) | ||
| A61K 38/12 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/10 | (2018.01) |
| (11) | Number of the document | 3626253 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19191344.1 |
| Date of filing the European patent application | 2011-08-11 | |
| (97) | Date of publication of the European application | 2020-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 37280410 P | 2010-08-11 | US |
| (72) |
MO, Yun , US
FRETZEN, Angelika , US
CALI, Brian , US
DEDHIYA, Mahendra , US
|
| (73) |
Ironwood Pharmaceuticals, Inc. ,
301 Binney Street, Cambridge, MA 02142,
US
Forest Laboratories Holdings Limited , Victoria Place, 5th Floor 31 Victoria Street, Hamilton, BM |
| (54) | STABLE FORMULATIONS OF LINACLOTIDE |
| STABLE FORMULATIONS OF LINACLOTIDE |